Evaxion Biotech AS (EVAX)

$1.30 -$0.06 (-4.26%) 4:38 PM 12/11/24
NASDAQ | $USD | Biotechnology

Stock Data

  • Market Cap

    $13.28M
  • Day's Range

    $1.20 - $1.30
  • Volume

    35,733
  • 52 Week Low / High

    $1.28 - $13.61
  • PE Ratio

    -
  • PEG Ratio

    -
  • Dividend Frequency

    -

EVAX's Dividend
-
Amount
-
Dividend Yield
-
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
1
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
$9.33
Target Price

Company News

  • EVAX Process Continues to Garner Interest and Investment — Sep 26th, 2024

    By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it ...

  • EVAX Process Continues to Garner Interest and Investment — Sep 26th, 2024

    By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it ...

  • EVAX Process Continues to Garner Interest and Investment — Sep 26th, 2024

    By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it ...

Similar Stocks

No similar stocks found.

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free